In a world built largely for right-handed people, left-handers often have to make a conscious effort just to use their right hand for everyday tasks. Right-handed people need to be more self-aware of this reality. There’s really no need to make a fuss about anything.
If you really want a serious healthy relationship you HAVE to cut off exes, people you used to date, and people you slept with! You can’t build nothing solid being halfway in. Gotta be all in and disciplined!
« Quand ils vous trahissent, c'est comme s'ils vous coupaient les bras. Vous pouvez leur pardonner, mais vous ne pouvez plus les serrer dans vos bras. »
Léon Tolstoï
The ovary is the first organ to age on a schedule. Fertility starts to fall around age 34, decades before the heart stiffens or the brain slows. We assume eggs wear out, that time wears them down the way it wears down everything else. A 2025 study found close to the opposite. By the mid-30s, aging eggs are not winding down. They are running hot.
That finding is the clearest human example yet of the hyperfunction theory of aging, an idea that quietly inverts what most of us assume aging to be.
The theory comes from Mikhail Blagosklonny, a cancer researcher who spent two decades arguing that we have the cause of aging backwards. We don’t grow old because the body breaks down, he said. We grow old because our cells stay stuck in growth mode.
The growth programs that turn a child into an adult are never switched off. They keep running into a stage of life where their intensity has become harmful instead of useful. Aging, in this view, is not decay. It is excess.
It is a strange thought to sit with. The same drive that builds you is the one that ages you. There is no separate aging program, only a growth program that does not know when to stop.
What is the engine behind this growth?
A pathway called mTOR (mechanistic target of rapamycin). Its job is to sense whether conditions are right for growth, then set the cell’s dial between building and maintaining.
When nutrients are plentiful, when growth signals are present, when the cell has what it needs to build, mTOR switches on and drives the machinery of growth: making proteins, building cellular structures, telling the cell to enlarge and divide.
When nutrients are scarce, mTOR quiets down, and the cell shifts from building to maintenance and recycling, switching on autophagy, the process by which it breaks down its own damaged proteins and worn-out components, reusing the parts to build what it needs and burning the rest for energy.
mTOR is, in effect, the master switch between growth mode and preservation mode, the molecular hand on the accelerator. For most of a life, that hand is an asset. The theory’s claim is that it never fully lifts.
Now look at the ovary.
If eggs simply wore out, an aging egg should look depleted: systems fading, maintenance genes dropping, the cell running low. So researchers read the gene-expression programs of human eggs and of the cumulus cells that surround and nourish them, in women from their twenties to their late forties.
What they found by the mid-30s:
• Ribosome genes, which build proteins, were turned up, not down.
• mTOR signaling was elevated and protein synthesis had increased.
• The nucleolus, the cell’s ribosome factory, had enlarged, and ribosomal RNA had climbed.
• Autophagy, the cell’s recycling and cleanup process, was reduced, and the lysosomes that digest cellular waste were less active.
• GPX4, a key antioxidant defense, had fallen.
Building cranked up. Maintenance turned down. The organ is not failing for lack of effort. It is failing from too much of it.
How does overdrive become damage?
First, at the level of the single cell. Cells are told to stop dividing all the time. A damaged, stressed, or potentially cancerous cell gets placed under arrest by molecular brakes, and that is usually protective. Blagosklonny drew a sharp line here: arrest alone is not senescence. In a healthy setting, an arrested cell goes quiet, drops into a low-activity resting state, and waits until it is needed or cleared away.
The twist is what happens if mTOR is still switched on.
The brakes hold, so the cell can’t multiply. But mTOR keeps pushing it to build. Blocked from dividing and driven to grow, the cell does the only thing left. It swells. It becomes large, flat, and misshapen, floods its surroundings with inflammatory signals, and enters cellular senescence: a bloated, dysfunctional cell that won’t divide and won’t die.
Blagosklonny called this geroconversion: growth with the brakes on. A drive with nowhere to go does not fail quietly. It is aging captured in a single cell.
Second, at the level of the egg itself. Older eggs are more likely to carry the wrong number of chromosomes (aneuploidy). This is the main reason fertility falls and miscarriage rises with age, and we have always described it as eggs wearing out. The 2025 data suggest we had the story pointed the wrong way. The chromosome errors sit downstream of the overdrive, not upstream of it.
The egg isn’t running out of gas. It is an engine held at redline, and it breaks under the strain.
There is an evolutionary logic that fits. Selection cares most about reproduction early in life, and its force fades with age. A program built to drive fertility hard in your twenties was never under pressure to shut itself down gracefully in your late thirties. Evolution tuned the young body and left the older one to keep running.
Then comes the test, the part that separates a good story from a real mechanism. If overdrive is the cause, easing it should help. Rapamycin, the mTOR inhibitor at the center of the theory, did that at three levels.
In cultured human cumulus cells, it brought runaway protein synthesis back down and reduced senescence markers. In aging mice, it quieted the same mTOR signals, lowered oxidative stress, improved egg maturation, and cut the chromosome-alignment errors that age introduces.
In women, it did what matters most. In the IVF trial, a few weeks of low-dose rapamycin before egg retrieval produced more good-quality embryos and raised the clinical pregnancy rate from 28% to 50%.
Now the limits.
The IVF trial was small. Rapamycin did not create new eggs or restore ovarian reserve, and the cleanest statistical signal was in embryo quality, not in the pregnancy rate. A 28% to 50% jump from a small trial should be read as conservatively. The mouse and cell work is preclinical, and it can’t tell us what happens in a woman’s ovary over years.
The theory itself also leans almost entirely on mTOR. A mouse and a whale share nearly the same pathway and age at vastly different rates, so mTOR can’t be the whole clock. The ovary may be an unusually clean case precisely because its program is so sharply timed. Most human aging is messier, a tangle of causes instead of one tidy program.
And damage is real. The more defensible claim is not that damage doesn’t exist, but that hyperfunction reaches a lethal threshold first, killing us before the damage would have. Most researchers now treat aging as a hybrid of both. Dr. João Pedro de Magalhães (@jpsenescence) has made a related case, that aging may be a continuation of developmental programs.
What does this change about how we think about interventions?
If aging is damage, you repair and protect. That was the logic of the antioxidant era, and it has largely disappointed. If aging is hyperfunction, the goal flips to restraint: ease the overactive growth programs instead of patching their wreckage.
The more useful question stops being which intervention works and becomes where it acts on the pathway.
Rapamycin turns the dial down directly. It inhibits mTOR itself, which makes it the cleanest test of the theory’s central question: if you turn growth signaling down, does aging slow? The ovary data point toward yes, and lifespan rises in animals too.
Caloric restriction and fasting act from upstream. They reduce the nutrient signals that tell mTOR to stay on, so the cell shifts toward maintenance without a drug ever touching the pathway.
Exercise complicates the picture, and that is where the theory gets interesting. Resistance training acutely raises mTOR in muscle, and that is how muscle gets built. The theory is about chronic, unchecked overdrive, not every pulse of growth signaling. A signal that rises and then falls with recovery is a different thing from one that never turns off. This paper did not test that.
That points to a broader lesson. The right setting likely depends on the tissue and the decade. Muscle needs mTOR high at times. An egg in its mid-30s appears to need it lower. The same drive we spend our twenties trying to amplify may be the one we spend our fifties trying to restrain.
So the question for any longevity intervention becomes mechanistic. What does it do to the balance between building and maintaining, in which tissue, and for how long?
The ovary is just the first place we can see it clearly. If the organ that ages first does so by excess rather than exhaustion, it is hard not to wonder how much of the rest of aging is the same story, told more slowly.
Aging may be less about what the body loses than about what it never learns to stop doing.
Know the Prominent Ghanaian figures featured on the newly introduced Heritage Series.
GH¢1 – Madam Agnes Oforiwa Tagoe-Quarcoopome: The prominent market woman and independence activist who mobilised Makola Market women to support Dr. Kwame Nkrumah. (She is currently on the 50 pesewas coin)
GH¢2 – Cardinal Peter Poreku Dery: Ghana’s first Catholic cardinal.
GH¢5 – Dr. James Emman Kwegyir Aggrey: A pioneering Ghanaian educator, missionary and intellectual who championed educational reforms for Africans.
GH¢10 – Justice Annie Ruth Jiagge: Ghana’s first female judge and a prominent international advocate for women’s rights.
GH¢20 – Dr. Ephraim Kwaku Amu: Celebrated Ghanaian composer, musicologist and educator best known for composing the patriotic song Yɛn Ara Asaase Ni.
GH¢50 – Theodosia Salome Okoh: Renowned Ghanaian artist credited for designing Ghana’s national flag in 1957.
GH¢100 – Kofi Annan: Ghanaian diplomat and Nobel Prize Winner who served as the seventh Secretary-General of the United Nations from 1997 to 2006.
GH¢200 – Dr. Kwame Nkrumah: Ghana’s first President.
A cheating man mistakes secrecy for power thinking he’s winning because one woman loves him loyally while he entertains another in the dark. Spiritually, you aren't winning a damn thing when you're actively vandalizing the very soul God trusted you to protect. You can seduce her with rehearsed apologies, sweet lies, and empty promises, but you can’t outsmart God with a rotten, double-minded heart.